Latest News for: the lancet

Edit

Elsevier Foundation and The Lancet Announce Winners of Inaugural Evidence to Impact Awards

PR Newswire 14 Jul 2026
LONDON, July 14, 2026 /PRNewswire/ -- The Elsevier Foundation and The Lancet announced today the three winning teams of the inaugural edition of The Lancet–Elsevier Foundation Evidence to Impact Awards.
Edit

InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in ...

Morgan Citizen 09 Jul 2026
NANJING, China, July 9, 2026 /PRNewswire/ -- InxMed Co., Ltd ...
Edit

InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation

PR Newswire 09 Jul 2026
... in The Lancet Respiratory Medicine ... "The publication of our long-term follow-up data in The Lancet Respiratory Medicine serves as a momentous validation of our translational science," said Dr.
Edit

ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing

Caledonian Record 07 Jul 2026
Investigational n.c.a. 177Lu-edotreotide (ITM-11) demonstrated a significantly higher progression-free survival and objective response rate vs. everolimus ....
Edit

When Medical Journals Sell Hate Propaganda: The Lancet Crosses the Line (Again)

Daily Alert 07 Jul 2026
The Lancet, founded in 1823, traffics in boycott campaigns targeting top doctors and medical researchers, and has transformed into a platform for hate that spits in the face of its neutral scientific mission.
Edit

KDventures' portfolio company AnaCardio's clinical study of drug candidate AC01 published in The Lancet (KDventures AB)

Public Technologies 25 Jun 2026
KDV) today announces that its portfolio company AnaCardio's phase 1b/2a study of the drug candidate AC01 has been published in The Lancet, one of the world's most prestigious medical journals ... The Lancet.
Edit

KDventures’ portfolio company AnaCardio’s clinical study of drug candidate AC01 published in The Lancet (KDventures AB)

Public Technologies 25 Jun 2026
KDV) today announces that its portfolio company AnaCardio's phase 1b/2a study of the drug candidate AC01 has been published in The Lancet, one of the world's most prestigious medical journals ... The Lancet.
Edit

AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet (Sound Bioventures Management AB)

Public Technologies 25 Jun 2026
Publication in The Lancet represents rigorous independent peer-reviewed recognition of the scientific and clinical relevance of the GOAL-HF1 data, underscoring both the distinctiveness of AC01 and the strength of the GOAL-HF1 results.
Edit

Indonesia partners with The Lancet to shape long-term medical strategy

Antara News 23 Jun 2026
Jakarta (ANTARA) - Indonesia's Health Ministry has partnered with The Lancet, one of the world's oldest and most prestigious peer-reviewed medical journals, to develop an evidence-based ...
Edit

Hantavirus Reveals Latin America Is Unprepared, Warns The Lancet Commentary

Business Wire 22 Jun 2026
MEXICO CITY--(BUSINESS WIRE)-- #InfectiousDiseases--The Latin American Technical Working Group, composed ...
Edit

Govt, The Lancet teams up improving RI's health system by research

Antara News 22 Jun 2026
During the launch of Commission for The Lancet Regional Health–Western Pacific ... The findings on those topics will be published in The Lancet Regional Health-Western Pacific.
Edit

IntraBio Announces Publication of Pivotal Phase III Data with Levacetylleucine for Ataxia-Telangiectasia in The Lancet Neurology

Hastings Tribune 18 Jun 2026
AUSTIN, Texas--(BUSINESS WIRE)--Jun 18, 2026-- ... .
Edit

PIVOTAL TRIAL OF AMEILE® PLUS CHEMOTHERAPY (AENEAS2) PUBLISHED IN THE LANCET ONCOLOGY (Hansoh Pharmaceutical Group Co Ltd)

Public Technologies 18 Jun 2026
) PIVOTAL TRIAL OF AMEILE® PLUS CHEMOTHERAPY (AENEAS2) PUBLISHED IN THE LANCET ONCOLOGY ... The Lancet Oncology is an authoritative sub-journal of the top international medical journal The Lancet, founded in 2000 by Lancet Publishing Group.
Edit

The Lancet publishes call to suspend Israeli Medical Association from global medical body

Virtual Jerusalem 14 Jun 2026
The World Medical Association however told The Lancet that it ...
Edit

Data Published in The Lancet Explores Potential Risk Reduction with KERENDIA® (finerenone) for Adults with Chronic Kidney Disease, With or Without Type 2 Diabetes (Bayer Corporation)

Public Technologies 05 Jun 2026
The Lancet published initial results from the INFINITY prespecified exploratory pooled analysis designed to evaluate KERENDIA® (finerenone) in adults with chronic kidney disease (CKD), including those ...

Article Search

tools
×
×
×
×